Cover Image

A Review of Discharge Medications in Patients Admitted with Acute Decompesated Heart Failure in a Tertiary Referral Centre

Background: National guidelines for heart failure recommend prescription of certain classes of drugs to improve prognosis in patients admitted with acute decompensated heart failure (ADHF). It has been noted during clinical follow up such patients are discharged with different treatment regimes....

Full description

Saved in:
Bibliographic Details
Main Authors: Chung, B.K., Ling, H.S., Chua, P.F., Fong, A.Y.Y.
Format: Article
Language:English
Published: Elsevier 2019
Subjects:
R Medicine (General)
Online Access:http://ir.unimas.my/id/eprint/33304/1/A%20Review%20of%20Discharge%20Medications%20in%20Patients%20Admitted%20withAcute%20Decompesated%20Heart%20Failure%20in%20a%20Tertiary%20Referral%20Centre.pdf
http://ir.unimas.my/id/eprint/33304/
https://www.clinicalkey.com/#!/content/playContent/1-s2.0-S0167527319354373?returnurl=https:%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS0167527319354373%3Fshowall%3Dtrue&referrer=https:%2F%2Fwww.internationaljournalofcardiology.com%2Farticle%2FS0167-5273(19)35437-3%2Fabstract
Tags: Add Tag
No Tags, Be the first to tag this record!
id my.unimas.ir.33304
record_format eprints
spelling my.unimas.ir.333042020-12-11T01:49:23Z http://ir.unimas.my/id/eprint/33304/ A Review of Discharge Medications in Patients Admitted with Acute Decompesated Heart Failure in a Tertiary Referral Centre Chung, B.K. Ling, H.S. Chua, P.F. Fong, A.Y.Y. R Medicine (General) Background: National guidelines for heart failure recommend prescription of certain classes of drugs to improve prognosis in patients admitted with acute decompensated heart failure (ADHF). It has been noted during clinical follow up such patients are discharged with different treatment regimes. Objective: To determine the relationship between drug treatment regimes in patients admitted to a tertiary referral centre with ADHF and their medium term clinical outcomes post-discharge, defined as 90-day mortality and hospital readmissions. Methods: 94 cases with a discharge diagnosis of ADHF were recruited from October 2017 until August 2018. Cases were analyzed retrospectively for their medications at discharge. Patients were followed-up for 90 days via phone. Results: Out of 94 patients, 8 patients died during admission. 86 patients were being analysed for clinical outcomes. 22 (26%) patients were discharged without a single type of guideline recommended medication for heart failure (GRM). 33 (38%) patients were discharged on one type, 22 (26%) patients discharged with two types and 10 (12%) patients were discharged with three or more types of GRM. The main reasons for not being discharged with all GRM were chronic kidney disease, obstructive lung disease, bradycardia and hypotension. The 90 days mortality rate was higher in patients discharged with ≤1 class of GRM drugs compared to patients with discharged on ≥2 classes of GRM drugs. (14.5% vs 6.5%; OR 2.25; 95%CI 0.51, 9.96; p=0.28). The 90 days readmission rate for ADHF was also higher for patients discharged with ≤1 class of GRM drugs (20.0% vs 12.9%; OR 1.55; 95%CI 0.539, 4.457; p=0.416). Overall, patients with discharged with ≤1 class of GRM drugs had also a higher 90-day event rate (27.3% vs 19.4%; OR 1.78; 95%CI 0.797, 3.993; p=0.16). Conclusions: Discharging ADHF patients with ≥2 class of GRM drugs was associated with lower 90 days readmission rates and mortality. Elsevier 2019 Article PeerReviewed text en http://ir.unimas.my/id/eprint/33304/1/A%20Review%20of%20Discharge%20Medications%20in%20Patients%20Admitted%20withAcute%20Decompesated%20Heart%20Failure%20in%20a%20Tertiary%20Referral%20Centre.pdf Chung, B.K. and Ling, H.S. and Chua, P.F. and Fong, A.Y.Y. (2019) A Review of Discharge Medications in Patients Admitted with Acute Decompesated Heart Failure in a Tertiary Referral Centre. International Journal of Cardiology, 297. p. 5. https://www.clinicalkey.com/#!/content/playContent/1-s2.0-S0167527319354373?returnurl=https:%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS0167527319354373%3Fshowall%3Dtrue&referrer=https:%2F%2Fwww.internationaljournalofcardiology.com%2Farticle%2FS0167-5273(19)35437-3%2Fabstract 10.1016/j.ijcard.2019.11.015
institution Universiti Malaysia Sarawak
building Centre for Academic Information Services (CAIS)
collection Institutional Repository
continent Asia
country Malaysia
content_provider Universiti Malaysia Sarawak
content_source UNIMAS Institutional Repository
url_provider http://ir.unimas.my/
language English
topic R Medicine (General)
spellingShingle R Medicine (General)
Chung, B.K.
Ling, H.S.
Chua, P.F.
Fong, A.Y.Y.
A Review of Discharge Medications in Patients Admitted with Acute Decompesated Heart Failure in a Tertiary Referral Centre
description Background: National guidelines for heart failure recommend prescription of certain classes of drugs to improve prognosis in patients admitted with acute decompensated heart failure (ADHF). It has been noted during clinical follow up such patients are discharged with different treatment regimes. Objective: To determine the relationship between drug treatment regimes in patients admitted to a tertiary referral centre with ADHF and their medium term clinical outcomes post-discharge, defined as 90-day mortality and hospital readmissions. Methods: 94 cases with a discharge diagnosis of ADHF were recruited from October 2017 until August 2018. Cases were analyzed retrospectively for their medications at discharge. Patients were followed-up for 90 days via phone. Results: Out of 94 patients, 8 patients died during admission. 86 patients were being analysed for clinical outcomes. 22 (26%) patients were discharged without a single type of guideline recommended medication for heart failure (GRM). 33 (38%) patients were discharged on one type, 22 (26%) patients discharged with two types and 10 (12%) patients were discharged with three or more types of GRM. The main reasons for not being discharged with all GRM were chronic kidney disease, obstructive lung disease, bradycardia and hypotension. The 90 days mortality rate was higher in patients discharged with ≤1 class of GRM drugs compared to patients with discharged on ≥2 classes of GRM drugs. (14.5% vs 6.5%; OR 2.25; 95%CI 0.51, 9.96; p=0.28). The 90 days readmission rate for ADHF was also higher for patients discharged with ≤1 class of GRM drugs (20.0% vs 12.9%; OR 1.55; 95%CI 0.539, 4.457; p=0.416). Overall, patients with discharged with ≤1 class of GRM drugs had also a higher 90-day event rate (27.3% vs 19.4%; OR 1.78; 95%CI 0.797, 3.993; p=0.16). Conclusions: Discharging ADHF patients with ≥2 class of GRM drugs was associated with lower 90 days readmission rates and mortality.
format Article
author Chung, B.K.
Ling, H.S.
Chua, P.F.
Fong, A.Y.Y.
author_facet Chung, B.K.
Ling, H.S.
Chua, P.F.
Fong, A.Y.Y.
author_sort Chung, B.K.
title A Review of Discharge Medications in Patients Admitted with Acute Decompesated Heart Failure in a Tertiary Referral Centre
title_short A Review of Discharge Medications in Patients Admitted with Acute Decompesated Heart Failure in a Tertiary Referral Centre
title_full A Review of Discharge Medications in Patients Admitted with Acute Decompesated Heart Failure in a Tertiary Referral Centre
title_fullStr A Review of Discharge Medications in Patients Admitted with Acute Decompesated Heart Failure in a Tertiary Referral Centre
title_full_unstemmed A Review of Discharge Medications in Patients Admitted with Acute Decompesated Heart Failure in a Tertiary Referral Centre
title_sort review of discharge medications in patients admitted with acute decompesated heart failure in a tertiary referral centre
publisher Elsevier
publishDate 2019
url http://ir.unimas.my/id/eprint/33304/1/A%20Review%20of%20Discharge%20Medications%20in%20Patients%20Admitted%20withAcute%20Decompesated%20Heart%20Failure%20in%20a%20Tertiary%20Referral%20Centre.pdf
http://ir.unimas.my/id/eprint/33304/
https://www.clinicalkey.com/#!/content/playContent/1-s2.0-S0167527319354373?returnurl=https:%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS0167527319354373%3Fshowall%3Dtrue&referrer=https:%2F%2Fwww.internationaljournalofcardiology.com%2Farticle%2FS0167-5273(19)35437-3%2Fabstract
_version_ 1687397409757331456
score 13.211869

Similar Items